Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

Also called NCT01790997

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 126 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01790997
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01790997. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
DLBS1033
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Lead sponsor
Dexa Medica Group (class: industry)

Record details

Record id
cardio:ct-nct01790997
Content hash
8687735adacdd786fd951f073a0df66694944f61323891a8a9f135fc58ecf1d1